Literature DB >> 9488425

Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium.

L L Perry1, K Feilzer, H D Caldwell.   

Abstract

Female mice bearing targeted mutations in the interleukin-6 or inducible nitric oxide synthase locus mounted effective immune responses following vaginal infection with Chlamydia trachomatis. Chlamydial clearance rates, local Th1 cytokine production, and host antibody responses were similar to those of immunocompetent control mice. Therefore, neither gene product appears to be critical for the resolution of chlamydial infections of the urogenital epithelium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488425      PMCID: PMC108045          DOI: 10.1128/IAI.66.3.1265-1269.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia.

Authors:  J U Igietseme; I M Uriri; R Hawkins; R G Rank
Journal:  J Leukoc Biol       Date:  1996-05       Impact factor: 4.962

2.  IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses.

Authors:  L Meyaard; E Hovenkamp; S A Otto; F Miedema
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

3.  Nitric oxide and septic shock.

Authors:  J P Cobb; R L Danner
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

4.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.

Authors:  H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen.

Authors:  I Vouldoukis; V Riveros-Moreno; B Dugas; F Ouaaz; P Bécherel; P Debré; S Moncada; M D Mossalayi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice.

Authors:  P Jacobs; D Radzioch; M M Stevenson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.

Authors:  C A Salkowski; S A Barber; G R Detore; S N Vogel
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.

Authors:  Z Chai; S Gatti; C Toniatti; V Poli; T Bartfai
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Authors:  Christine Roshick; Heidi Wood; Harlan D Caldwell; Grant McClarty
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease.

Authors:  Jin Huang; Fred J DeGraves; Stephen D Lenz; Dongya Gao; Pu Feng; Dan Li; Tobias Schlapp; Bernhard Kaltenboeck
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Time-dependent disruption of oviduct pacemaker cells by Chlamydia infection in mice.

Authors:  Rose Ellen Dixon; Kyle H Ramsey; Justin H Schripsema; Kenton M Sanders; Sean M Ward
Journal:  Biol Reprod       Date:  2010-04-28       Impact factor: 4.285

5.  Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection.

Authors:  K A Kelly; J C Walker; S H Jameel; H L Gray; R G Rank
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

7.  A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection.

Authors:  D M Williams; B G Grubbs; T Darville; K Kelly; R G Rank
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 8.  Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights.

Authors:  Ruijin Shao; Sean X Zhang; Birgitta Weijdegård; Shien Zou; Emil Egecioglu; Anders Norström; Mats Brännström; Håkan Billig
Journal:  Mol Hum Reprod       Date:  2010-07-20       Impact factor: 4.025

9.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

10.  Perforin-2 restricts growth of Chlamydia trachomatis in macrophages.

Authors:  K A Fields; R McCormack; L R de Armas; E R Podack
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.